December 2007. Volume 3. Number 4

Folic acid fortification of flour and cereal products decreases the rate of neural-tube defects

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Referencia: De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Eng J Med. 2007;357:135-42
Reviewers: Esparza Olcina MJ1, Aizpurua Galdeano P2.
1Centro de Salud Barcelona. Móstoles. Madrid. España.
2ABS 7 La Salut Badalona. Badalona. España.
Correspondence: María Jesús Esparza Olcina. Email: mjesparza8@gmail.com
Reception date: 30/10/2007
Acceptance date: 09/11/2007
Publication date: 01/12/2007

Abstract


How to cite this article

Esparza Olcina MJ, Aizpurua Galdeano P. La fortificación de las harinas y cereales con ácido fólico disminuye la prevalencia de defectos del tubo neural. Evid Pediatr. 2007;3:94.

AVC | Critically appraised articles

Referencia: De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Eng J Med. 2007;357:135-42
Reviewers: Esparza Olcina MJ1, Aizpurua Galdeano P2.
1Centro de Salud Barcelona. Móstoles. Madrid. España.
2ABS 7 La Salut Badalona. Badalona. España.
Correspondence: María Jesús Esparza Olcina. Email: mjesparza8@gmail.com
Reception date: 30/10/2007
Acceptance date: 09/11/2007
Publication date: 01/12/2007

How to cite this article

Esparza Olcina MJ, Aizpurua Galdeano P. La fortificación de las harinas y cereales con ácido fólico disminuye la prevalencia de defectos del tubo neural. Evid Pediatr. 2007;3:94.

References

  1. Lumley J, Watson L, Watson M, Bower C. Suplementación periconcepcional con folato y/o multivitaminas para la prevención de los defectos del tubo neural (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 3. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.).
  2. Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD. Decline in the Prevalence of Spina Bifida and Anencephaly by Race/Ethnicity: 1995–2002. Pediatrics. 2005;116:580-6.
  3. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural tube defects with folic acid in China. N Engl J Med. 1999;341:1485-90.
  4. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ. 2005;330:571.
  5. Gonzalez de Dios J, Ochoa Sangrador C. Las madres gestantes en España toman el ácido fólico para la prevención primaria de defectos congénitos a destiempo y a dosis muy elevadas. Evid Pediatr. 2007;3:64.
  6. Rader JI, Schneeman BO. Prevalence of Neural Tube Defects, Folate Status, and Folate Fortification of Enriched Cereal-Grain Products in the United States. Pediatrics. 2006;117:1394-9.
  7. Centre for Reviews and Dissemination. NHS Economic Evaluation Database (NHS EED) - Full record display. Romano P S, Waitzman NJ, Scheffler R M, Pi RD. Folic acid fortification of grain: an economic analysis [en línea][consultado:30-X-2007]. Disponible en: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&ID=21995000636
  8. EUROCAT. European Surveillance of Congenital Anomalies [en línea][consultado: 9-XI-2007]. Disponible en: http://www.eurocat.ulster.ac.uk/
01/12/2007

Linked Comment